NCT00114556View on ClinicalTrials.gov

The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

August 31, 2004

Conditions
OsteoporosisLiver TransplantationFractures
Interventions
DRUG

zoledronic acid

Trial Locations (1)

2050

Royal Prince Alfred Hospital, Sydney

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Royal Prince Alfred Hospital, Sydney, Australia

OTHER